Clinical Trial Update: A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed whether adding lenvatinib to Ifosfamide and Etoposide improves outcomes for children, adolescents, and young adults with relapsed or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: Eisai Inc. | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2023-08-07